Last reviewed · How we verify

NCT06095349: FORST3

Effect of Sulfur Thermal Water on Circulating H2S Levels and Markers of Bone Metabolism in Osteopenic Subjects.

Completed NA Last updated 19 January 2024
What this trial tests

NA trial testing inhalatory treatment with sulfureous aerosol in Hydrogen Sulfide in 50 participants. Completed in 30 November 2023.

Timeline
1 October 2019
Primary endpoint
30 November 2023
30 November 2023

Quick facts

Lead sponsorIstituto Ortopedico Rizzoli
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment50
Start date1 October 2019
Primary completion30 November 2023
Estimated completion30 November 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Istituto Ortopedico Rizzoli — full company profile →

Who can join

Adults 50 to 60, female only, with Hydrogen Sulfide or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate whether inhalation treatment with high-sulfide waters from some spas (referred to as "thermal waters"), performed for 12 consecutive days, is able to change circulating H2S levels and alter bone metabolism. Identifying a clear correlation between circulating levels of H2S and sulfur water administration, as well as a potential anabolic effect on bone, would set the stage for new studies that could have important clinical implications for promoting health and preventing osteoporosis

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Reactive Sulfur Species and Protein Persulfidation: An Emerging Redox Axis in Human Health and Disease.
    Andrés CMC, Lobo F, Lastra JMP, Munguira EB, et al · · 2025 · cited 7× · PMID 41020887 · DOI 10.3390/cimb47090765
  2. Changes in Oxidative Stress, Inflammatory and Bone Metabolism Biomarkers Following Sulfurous Water Inhalation in Osteopenic Women.
    Gambari L, Amore E, Roseti L, Carpentieri S, et al · · 2026 · PMID 41977347 · DOI 10.3390/ijms27073163

Verify or expand the search:

Other recruiting trials for Hydrogen Sulfide

Currently open trials in the same condition.

Other Istituto Ortopedico Rizzoli trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06095349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing